Craniofacial fibrous dysplasia: A 10-case series.

[1]  H. de Boysson,et al.  Tocilizumab in the treatment of a polyostotic variant of fibrous dysplasia of bone. , 2015, Rheumatology.

[2]  R. Chapurlat,et al.  Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment. , 2014, Joint, bone, spine : revue du rhumatisme.

[3]  A. Feydy,et al.  Fibrous dysplasia and McCune-Albright syndrome: imaging for positive and differential diagnoses, prognosis, and follow-up guidelines. , 2014, European journal of radiology.

[4]  F. Chabolle,et al.  Chirurgie des dysplasies fibreuses craniofaciales : une approche fonctionnelle , 2013 .

[5]  S. Aubert,et al.  Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions , 2013, Modern Pathology.

[6]  Eun Hee Lee,et al.  The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases. , 2012, Human pathology.

[7]  B. Sacchetti,et al.  Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  Ying-Chien Tan,et al.  Optic Nerve Compression in Craniofacial Fibrous Dysplasia: The Role and Indications for Decompression , 2007, Plastic and reconstructive surgery.

[9]  A. Leet,et al.  Onset, Progression, and Plateau of Skeletal Lesions in Fibrous Dysplasia and the Relationship to Functional Outcome , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Janice S. Lee,et al.  LONG‐TERM OUTCOME OF OPTIC NERVE ENCASEMENT AND OPTIC NERVE DECOMPRESSION IN PATIENTS WITH FIBROUS DYSPLASIA: RISK FACTORS FOR BLINDNESS AND SAFETY OF OBSERVATION , 2006, Neurosurgery.

[11]  R. Salgado,et al.  Tumors and tumor-like lesions of the jaw: radiolucent lesions. , 2006, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

[12]  S. Wientroub,et al.  An Instrument to Measure Skeletal Burden and Predict Functional Outcome in Fibrous Dysplasia of Bone , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  P. Delmas,et al.  Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. , 2004, Bone.

[14]  F. Glorieux,et al.  Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. , 2003, The Journal of clinical endocrinology and metabolism.

[15]  P. Bianco,et al.  Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. , 2003, Bone.

[16]  Edmond FitzGibbon,et al.  Normal vision despite narrowing of the optic canal in fibrous dysplasia. , 2002, The New England journal of medicine.

[17]  E. McCarthy,et al.  Fibrous dysplasia involving the skull base and temporal bone. , 2001, Archives of otolaryngology--head & neck surgery.

[18]  Safdar N. Khan,et al.  Bisphosphonate Therapy in Fibrous Dysplasia , 2001, Clinical orthopaedics and related research.

[19]  J. Nerad,et al.  Ophthalmic manifestations of fibrous dysplasia: a disease of children and adults. , 1998, Ophthalmology.

[20]  R. Weinstein.  Long‐Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  Yu-Ray Chen,et al.  Optic Nerve Decompression in Fibrous Dysplasia: Indications, Efficacy, and Safety , 1997, Plastic and reconstructive surgery.

[22]  K. Ozono,et al.  Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. , 1996, The Journal of clinical investigation.

[23]  P. Delmas,et al.  Long‐Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone , 1997, Lancet.

[24]  Pietro Ruggieri,et al.  Malignancies in fibrous dysplasia , 1994, Cancer.

[25]  P. Macpherson,et al.  Fibrous dysplasia of the skull: disease activity in relation to age. , 1991, The British journal of radiology.

[26]  Y. R. Chen,et al.  Fronto‐orbito-sphenoidal Fibrous Dysplasia , 1985, Annals of plastic surgery.